Back to Search

GEORGE SCHREINER, MD

MD

Psychologist

NPI: 1710102835Individual

Specialties, Licenses & Credentials

PsychologistPrimary

Psychologist

Code: 103T00000X

919(LA)
Intellectual & Developmental Disabilities Psychologist

Psychologist — Intellectual & Developmental Disabilities

Code: 103TM1800X

919(LA)
Cognitive & Behavioral Psychologist

Psychologist — Cognitive & Behavioral

Code: 103TB0200X

Research & Publications (20)

Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
PMID 18091407·Crit Pathw Cardiol·2007
3-trial
Decreasing the use of mechanical restraints and locked seclusion.
PMID 15478875·Adm Policy Ment Health·2004
8-other
Role of the microvascular endothelium in progressive renal disease.
PMID 11856789·J Am Soc Nephrol·2002
6-review
Improvement of human islet cryopreservation by a p38 MAPK inhibitor.
PMID 17331110·Am J Transplant·2007
7-preclinical
Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
PMID 17349887·J Am Coll Cardiol·2007
8-other
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia.
PMID 17724276·Hypertension·2007
7-preclinical
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
PMID 16857807·Clin Cancer Res·2006
7-preclinical
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
PMID 16600214·Exp Cell Res·2006
7-preclinical
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
PMID 16603672·J Pharmacol Exp Ther·2006
4-observational
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
PMID 16617327·Leukemia·2006
4-observational
Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension.
PMID 16804104·Am J Physiol Renal Physiol·2006
7-preclinical
Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.
PMID 16751295·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Affymetrix oligonucleotide analysis of gene expression in the injured heart.
PMID 16010026·Methods Mol Med·2005
6-review
Nesiritide--not verified.
PMID 16211709·N Engl J Med·2005
8-other
Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts.
PMID 15716330·J Am Soc Nephrol·2005
7-preclinical
Inhibition of p38 mitogen-activated protein kinase protects human islets from cryoinjury and improves the yield, viability, and quality of frozen-thawed islets.
PMID 16298615·Transplant Proc·2005
8-other
TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
PMID 15253713·Kidney Int·2004
7-preclinical
p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats.
PMID 15454858·J Cardiovasc Pharmacol·2004
4-observational
p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
PMID 15480425·Oncogene·2004
8-other
p38 Inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells.
PMID 15572041·J Mol Cell Cardiol·2004
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
620 N. MORRISON,, SUITE G
HAMMOND, LA 70401

Location

Practice Location

620 N. MORRISON,, HAMMOND, LA
(985) 543-4113

Quick Facts

NPI
1710102835
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
20

Are you this provider?

Claim Your Profile